99% Savings - Buy Just @1 Rs X
Xigduo XR Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Diabetes Type 2, Diabetes.
The right dosage of Xigduo XR Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Xigduo XR Tablet include Stomach Upset, Difficulty urinating. While these are the most often observed Xigduo XR Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Xigduo XR Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Xigduo XR Tablet's effect during pregnancy is Mild and Moderate while nursing. In addition, Xigduo XR Tablet's effects on the liver, heart and kidney are discussed below in the Xigduo XR Tablet related warnings section.
Xigduo XR Tablet is contraindicated in people with pre-existing medical conditions like Bladder Cancer, Kidney Disease, Congestive Heart Failure (CHF) as it can result in adverse effects. Some other conditions that can be affected by Xigduo XR Tablet are listed in the contraindications section below.
Additionally, Xigduo XR Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Xigduo XR Tablet is considered safe while driving, and is addictive.
Xigduo XR Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Xigduo XR Tablet safe for pregnant women?
Pregnant women may get mild side effects from Xigduo XR Tablet.
Is the use of Xigduo XR Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Xigduo XR Tablet. Immediately discontinue Xigduo XR Tablet if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Xigduo XR Tablet on the Kidneys?
Xigduo XR Tablet is not harmful for kidneys.
What is the effect of Xigduo XR Tablet on the Liver?
Xigduo XR Tablet is not harmful for the liver.
What is the effect of Xigduo XR Tablet on the Heart?
You can take Xigduo XR Tablet without any fear of damage to the heart.
Xigduo XR Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Xigduo XR Tablet unless your doctor advises you to do so -
Is this Xigduo XR Tablet habit forming or addictive?
Xigduo XR Tablet does not cause addiction.
Interaction between Food and Xigduo XR Tablet
Due to the absence of research, it is difficult to say how Xigduo XR Tablet and food will interact.
Interaction between Alcohol and Xigduo XR Tablet
Taking Xigduo XR Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826